Evaluation of a new model for psychiatric inpatient care
Evaluation of a New Recovery-oriented Model of Care on Psychiatric Inpatient Wards.
This study tests a new way of organizing psychiatric hospital wards to see if it helps patients feel more involved in their care and improves their overall experience.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 1 site (Thônex) |
| Trial ID | NCT06250296 on ClinicalTrials.gov |
What this trial studies
This project examines the effects of reorganizing psychiatric inpatient wards to enhance individualized care, family integration, and patient participation in treatment planning. Initially implemented as a pilot on one acute psychiatric ward, the new recovery-oriented model will be assessed over 18 months, with comparisons made to two other wards. The study aims to evaluate outcomes such as the use of coercive measures, length of stay, clinical improvement, patient satisfaction, and overall ward atmosphere.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and over, hospitalized in the participating wards, and fluent in French.
Not a fit: Patients with dementia or those unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved patient experiences and outcomes in psychiatric care.
How similar studies have performed: Other studies have shown positive outcomes with similar recovery-oriented approaches in psychiatric care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients hospitalized in one of the three participating wards Exclusion Criteria: * Incapacity to give informed consent * Insufficient knowledge of French
Where this trial is running
Thônex
- HUG - Hôpital de Belle-Idée — Thônex, Switzerland (Recruiting)
Study contacts
- Principal investigator: Alexandre Wullschleger, MD — University Hospital, Geneva
- Study coordinator: Alexandre Wullschleger, MD
- Email: alexandre.wullschleger@hcuge.ch
- Phone: +41795534904
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.